# Program 1 Phase I0 - Production Governance Consolidation

Phase I consolidates production governance for the read-only clinical workflow foundation built through B-H.

## What B-H Built

- B: clinical readiness previews, snapshots, audit and snapshot history.
- C: human acknowledgment semantics and acknowledgment persistence/runtime boundaries.
- D: findings, extraction contracts, open questions, and read-only APIs/workspaces.
- E: review workflow foundation, documentation-only with passive schemas.
- F: Clinical Evidence Timeline foundation, documentation-first with passive schemas.
- G: GET-only Clinical Evidence Timeline read API.
- H: read-only Clinical Evidence Timeline workspace in Patient Workspace.

## What I0 Does Not Approve

I0 does not approve production, real patient data, new endpoints, new UI, new services, new DB models, migrations, permission seeds, Task engine, Outcome Evidence, patient messaging, automatic diagnosis, automatic treatment, appointment status changes or runtime workflow enforcement.

## Governance Scope

Phase I consolidates:

- production no-go status
- real patient data no-go status
- access-control and permission review
- audit, retention and export review
- backup/restore and data integrity review
- legal, compliance, GDPR/DPIA and certification claim review
- CI/release gate expectations
- known limitations and pilot release boundaries

## Decision

ASTRA remains demo/pilot-only with demo data. The read-only clinical workflow foundation is useful for controlled demonstration and pilot review, but it is not production-ready and is not approved for real patient data.

